Explore the full record of transactions filed by 정해민, Chief Executive Officer. Insider active across 2 companies, notably 엑셀세라퓨틱스. Cumulatively, 17,943 filings have been published. Activity tracked since 4 March 2026. The latest transaction was disclosed on 4 March 2026 (Purchase). Regulator: DART (FSS). The full history is free.
Jeong Hae-min is the executive director at Excel Therapeutics, where he oversees the company's operations and strategies. With a strong background in the sector, he is responsible for implementing initiatives aimed at fostering innovation and growth. His leadership is essential in guiding Excel Therapeutics towards a prosperous future.